A
1.26
0.00 (0.00%)
| 前收盘价格 | 1.26 |
| 收盘价格 | 1.23 |
| 成交量 | 166,512 |
| 平均成交量 (3个月) | 2,052,185 |
| 市值 | 19,380,816 |
| 价格/销量 (P/S) | 205.85 |
| 股市价格/股市净资产 (P/B) | 1.58 |
| 52周波幅 |
| 营业利益率 (TTM) | -5,822.92% |
| 稀释每股收益 (EPS TTM) | -2.89 |
| 季度收入增长率 (YOY) | 75.60% |
| 总债务/股东权益 (D/E MRQ) | 149.87% |
| 流动比率 (MRQ) | 2.89 |
| 营业现金流 (OCF TTM) | -29.93 M |
| 杠杆自由现金流 (LFCF TTM) | -28.82 M |
| 资产报酬率 (ROA TTM) | -82.76% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 看跌 | 混合的 |
| Medical Devices (全球的) | 看跌 | 混合的 | |
| 股票 | Adagio Medical Holdings, Inc | - | - |
AIStockmoo 评分
-1.8
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -3.0 |
| 平均 | -1.75 |
|
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 内部持股比例 | 0.29% |
| 机构持股比例 | 85.46% |
该时间范围内无数据。
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 15 May 2025 | 公告 | Adagio Medical Reports First Quarter 2025 Results |
| 07 May 2025 | 公告 | Adagio Medical to Present at the BofA Securities 2025 Health Care Conference |
| 17 Apr 2025 | 公告 | Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System |
| 31 Mar 2025 | 公告 | Adagio Medical Reports Fourth Quarter and Full Year 2024 Results |
| 31 Mar 2025 | 公告 | Adagio Medical Appoints Deborah Kaster as Chief Business Officer |
| 17 Mar 2025 | 公告 | Adagio Medical Provides Clinical and Business Updates |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合